COVID-19 in pediatrics: The current knowledge and practice

Autor: Mehraeen, Esmaeil, Oliaei, Shahram, SeyedAlinaghi, SeyedAhmad, Karimi, Amirali, Mirzapour, Pegah, Afsahi, Amir Masoud, Barzegary, Alireza, Vahedi, Farzin, Soleymanzadeh, Mahdi, Behnezhad, Farzane, Javaherian, Mohammad, Zargari, Ghazal, Mirghaderi, Seyed Peyman, Noori, Tayebeh, Sabatier, Jean-Marc

Publikováno v: Infectious Disorders-Drug Targets
Infectious Disorders-Drug Targets, Bentham Science Publishers, 2021, 21, ⟨10.2174/1871526521666210929121705⟩
Infectious Disorders-Drug Targets, 2021, 21, ⟨10.2174/1871526521666210929121705⟩

International audience; Introduction: SARS-CoV-2 is the novel coronavirus that causes severe acute respiratory syndrome and could afflict individuals from all walks of life. Children are usually asymptomatic or represent non-specific mild to moderate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::be637dc273ae35c9a7b595c677e38357
https://hal-amu.archives-ouvertes.fr/hal-03360217

Prevalence and reasons of loss to follow-up in HIV clinics: a systematic review of current evidence.

Autor: SeyedAlinaghi, SeyedAhmad, Karimi, Amirali, Barzegary, Alireza, Pashaei, Zahra, Zargari, Ghazal, Kianzad, Shaghayegh, MohsseniPour, Mehrzad, Mirzapour, Pegah, Fakhfouri, Amirata, Mehraeen, Esmaeil, Dadras, Omid

Publikováno v: HIV & AIDS Review; 2022, Vol. 21 Issue 3, p179-190, 12p

COVID-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice.

Autor: Mehraeen E; Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran., Oliaei S; HBOT Research Center, Golestan Hospital, Islamic Republic of Iran, Navy and AJA Medical University, Tehran, Iran., SeyedAlinaghi S; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran., Karimi A; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Mirzapour P; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran., Afsahi AM; Department of Radiology, School of Medicine, University of California, San Diego (UCSD), CA, USA., Barzegary A; School of Medicine, Islamic Azad University, Tehran, Iran., Vahedi F; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Soleymanzadeh M; Ophthalmology Resident at Farabi Hospital, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran., Behnezhad F; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Javaherian M; Department of Physiotherapy, Tehran University of Medical Sciences, Tehran, Iran., Zargari G; School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Mirghaderi SP; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Noori T; Department of Health Information Technology, Zabol University of Medical Sciences, Zabol, Iran., Sabatier JM; Université Aix-Marseille, Institut de Neuro-physiopathologie (INP), UMR 7051, Faculté de Pharmacie, 27 Bd Jean Moulin, 13385, Marseille Cedex, France.

Publikováno v: Infectious disorders drug targets [Infect Disord Drug Targets] 2022; Vol. 22 (5), pp. e290921196908.